Literature DB >> 2343828

Doppler echocardiographic flow velocity measurements in the superior vena cava during the Valsalva maneuver in normal subjects.

A J Gindea1, J Slater, I Kronzon.   

Abstract

The hemodynamic manifestations of the Valsalva maneuver are in part the result of changes in the venous return accompanying changes in intrathoracic pressure. Doppler echocardiography was performed during Valsalva maneuver in 13 normal subjects. Superior vena cava flow velocities and flow velocity integrals were measured in all 13 subjects. In the 5 subjects in whom the superior vena cava was clearly visualized throughout the maneuver, vena cava diameter was also analyzed. The superior vena cava flow velocity integral at rest was 17 +/- 2 cm. It diminished significantly, disappeared or reversed (-13 +/- 6 cm, p less than 0.001) with phase I of the maneuver. During the maintenance phase (phase II), the flow velocity integral increased significantly (31 +/- 2 cm, p = 0.05 vs baseline and phase I) and was associated with a decrease in superior vena cava lumen diameter at the time of Valsalva and continuing throughout the strain. With release of the maneuver (phase III), there was a sudden significant increase in flow velocity integral (61 +/- 2 cm, p = 0.005 vs phase II) and superior vena cava lumen diameter. Subsequently, superior vena cava flow velocity integral returned to baseline values. This study suggests that one of the ways in which the Valsalva maneuver leads to decreased venous return may be by direct external compression of the superior vena cava.

Mesh:

Year:  1990        PMID: 2343828     DOI: 10.1016/0002-9149(90)91333-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

1.  Superior vena cava flow in newborn infants: a novel marker of systemic blood flow.

Authors:  M Kluckow; N Evans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

Review 2.  Echocardiography of the superior vena cava.

Authors:  Rami N Khouzam; Daniel Minderman; Ivan A D'Cruz
Journal:  Clin Cardiol       Date:  2005-08       Impact factor: 2.882

3.  Real-time phase-contrast flow MRI of the ascending aorta and superior vena cava as a function of intrathoracic pressure (Valsalva manoeuvre).

Authors:  J T Kowallick; A A Joseph; C Unterberg-Buchwald; M Fasshauer; K van Wijk; K D Merboldt; D Voit; J Frahm; J Lotz; J M Sohns
Journal:  Br J Radiol       Date:  2014-07-30       Impact factor: 3.039

4.  Suprasternal optical window to Doppler the superior vena cava in neonates.

Authors:  Arvind Sehgal
Journal:  J Echocardiogr       Date:  2010-11-03

5.  Arterial pressure changes during the Valsalva maneuver to predict fluid responsiveness in spontaneously breathing patients.

Authors:  Manuel Ignacio Monge García; Anselmo Gil Cano; Juan Carlos Díaz Monrové
Journal:  Intensive Care Med       Date:  2008-10-02       Impact factor: 17.440

6.  The value of a superior vena cava collapsibility index measured with a miniaturized transoesophageal monoplane continuous echocardiography probe to predict fluid responsiveness compared to stroke volume variations in open major vascular surgery: a prospective cohort study.

Authors:  Şerban-Ion Bubenek-Turconi; Adham Hendy; Sorin Băilă; Anca Drăgan; Ovidiu Chioncel; Liana Văleanu; Bianca Moroșanu; Vlad-Anton Iliescu
Journal:  J Clin Monit Comput       Date:  2019-07-05       Impact factor: 2.502

7.  Simultaneous beat-by-beat investigation of the effects of the Valsalva maneuver on left and right ventricular filling and the possible mechanism.

Authors:  Zhen Wang; Li-jun Yuan; Tie-sheng Cao; Yong Yang; Yun-you Duan; Chang-yang Xing
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

8.  Three simple but interesting transthoracic echocardiographic road maps for proximal superior vena cava visualisation in healthy young adults.

Authors:  Mohammadbagher Sharifkazemi; Gholamreza Rezaian; Elham Hosseininejad; Alireza Arjangzadeh
Journal:  Int J Cardiol Heart Vasc       Date:  2022-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.